VaDDC
  • About
    • Join VaDDC
    • Affiliated Organizations
  • Leadership
    • Executive committee members
  • Events
    • VaDDRx 2022: Cardiovascular, Pulmonary, and Metabolic Disease
    • VaDDRx: CoronaVirus Therapeutics, Present and Future 2021
    • VaDDRx: Emerging Targets, Technologies and Therapeutics for Cancer and Neuroscience 2019
    • VirginiaDrugDiscoveryRx 2018
    • VirginiaCancerRx 2017
    • VirginiaBrainRx 2016
  • News
  • Partnerships
    • Industry Initiatives
    • Featured Collaborations
    • Become a Sponsor
Select Page

20190409_Logos

by Discovery | Apr 9, 2019

Recent Posts

  • Exec. Committee Member Beth Sharlow on UVA’s Fiske Drug Discovery Lab
  • KeViRx Selected as Part of BLUE KNIGHT™ Collaboration for Global Health Preparedness
  • Desai Grant on Factor XIa Inhibitors Funded
  • KeViRx-UVA-ODU Collaborative SBIR Grant funded
  • Paul Carlier, Chair of the VaDDC, Receives Grant to Study Promising Antimalarial Drugs

Archives

  • March 2022
  • February 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • June 2020
  • May 2020
  • July 2019
  • March 2019
  • December 2018
  • November 2018
  • September 2018
  • September 2017
  • June 2017
  • May 2017
  • February 2017
  • December 2016
  • November 2016
  • September 2016
  • July 2016
  • April 2015
© 2016 Virginia Drug Discovery Consortium | website by michaelclapp.info